Articles

Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy

Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
Department of Population Sciences, City of Hope National Medical Center, Duarte, CA
Department of Population Sciences, City of Hope National Medical Center, Duarte, CA
Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
Vol. 108 No. 12 (2023): December, 2023 https://doi.org/10.3324/haematol.2023.282781